Zobrazeno 1 - 10
of 615
pro vyhledávání: '"John H. Laragh"'
Publikováno v:
American Journal of Hypertension. 26:727-738
Background Four recent reports revealed differences in survival rates among treated cardiovascular patients taking renin-angiotensin system–blocking drugs. Patients with higher on-treatment plasma renin activity (PRA) levels died sooner of cardiova
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 10, Iss 6, Pp 35-41 (2011)
The extent to which the clinical effects of angiotensin receptor blockers (ARB) are related to ambient renin system activity remains poorly defined. Therefore, we measured blood pressure (BP), large (C1) and small (C2) arterial compliance, systemic v
Publikováno v:
American Journal of Hypertension. 24:1181-1186
Background Plasma renin activity (PRA) has been associated with cardiovascular disease mortality (CVD) events among hypertensive patients. We now report a long-term follow-up to assess the enduring association of PRA to CVD and all-cause mortality. m
Autor:
Carmen Merali, Curt H. Grob, Jan Basile, Daniel T. Lackland, Christine Walters, Phillip B. Davis, Jessica Flynn Riehle, Shakaib U. Rehman, John H. Laragh, Brent M. Egan, Jean E. Sealey
Publikováno v:
American Journal of Hypertension. 22:792-801
Undefined pathophysiologic mechanisms likely contribute to unsuccessful antihypertensive drug therapy. The renin test-guided therapeutic (RTGT) algorithm is based on the concept that, irrespective of current drug treatments, subnormal plasma renin ac
Autor:
Tilman B. Drüeke, R. Brian Haynes, Suzanne Oparil, Theodore W. Kurtz, Judith S. Stern, Giuseppe Mancia, Priscilla Kincaid-Smith, Stuart L. Linas, Michael H. Alderman, Alexander G. Logan, David A. McCarron, Jan A. Staessen, Sharon Anderson, Friedrich C. Luft, William M. Bennett, John H. Laragh
Publikováno v:
Scopus-Elsevier
ResearcherID
ResearcherID
Nutrition Reviews has had a continuing interest in the scientific basis of arguments for and against health claims on foods. Such claims were first authorized by the Food and Drug Administration (FDA) in 1993 under the terms of the Nutrition Labellin
Publikováno v:
Acta Medica Scandinavica. 219:45-53
The renin angiotensin system is activated in the majority of patients with chronic congestive heart failure of moderate to severe symptomology. Renin release may result from one of several different stimuli: renal tubular sodium delivery and sensing
Autor:
Jean E. Sealey, John H. Laragh
Publikováno v:
American Journal of Hypertension. 22:112-121
Background Suppressed baseline plasma renin activity (PRA) levels or large reactive increases in renin secretion are two possible reasons for treatment failure with antirenin system drugs. Methods To investigate their prevalence we reanalyzed data fr
Autor:
Jean E. Sealey, John H. Laragh
Publikováno v:
American Journal of Hypertension. 20:587-597
A review of six clinical trials of aliskiren involving >5,000 patients with mild to moderate hypertension indicated that this first of a new class of orally active antihypertensive drugs is no more effective than angiotensin-converting enzyme inhibit
Publikováno v:
Polskie Archiwum Medycyny Wewnetrznej. 125(9)
To study the blood pressure, ionic, and hormonal responses to chronic dietary salt loading, we measured RBC pHi, Mgi, Nai, and Cai, and compared these with serum levels of Ca-io, 1,25-D, and free levels of PHF in salt-sensitive and salt-insensitive e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fabba77e719fc044df7e68dc48fc7c95
https://doi.org/10.1159/000420128
https://doi.org/10.1159/000420128